Cargando…

Monoclonal gammopathy of undetermined significance in Chinese population: A prospective epidemiological study

The aim of this study was to identify the prevalence of monoclonal gammopathy of undetermined significance (MGUS) in different groups of age and the clinical features in China. This multicenter prospective study enrolled 1797 health subjects. The overall prevalence of MGUS was 2.73%. The prevalence...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Ling, Xu, Shuang, Qu, Jianhua, Hou, Jian, Wang, Yang, Wen, Lei, Liu, Yang, Kang, Ying, Jiang, Ming, Fu, Weijun, Du, Juan, Zhou, Lin, Huang, Xiaojun, Zhang, Zhaoxia, Lu, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585751/
https://www.ncbi.nlm.nih.gov/pubmed/30117173
http://dx.doi.org/10.1002/hon.2548
_version_ 1783428765678829568
author Ma, Ling
Xu, Shuang
Qu, Jianhua
Hou, Jian
Wang, Yang
Wen, Lei
Liu, Yang
Kang, Ying
Jiang, Ming
Fu, Weijun
Du, Juan
Zhou, Lin
Huang, Xiaojun
Zhang, Zhaoxia
Lu, Jin
author_facet Ma, Ling
Xu, Shuang
Qu, Jianhua
Hou, Jian
Wang, Yang
Wen, Lei
Liu, Yang
Kang, Ying
Jiang, Ming
Fu, Weijun
Du, Juan
Zhou, Lin
Huang, Xiaojun
Zhang, Zhaoxia
Lu, Jin
author_sort Ma, Ling
collection PubMed
description The aim of this study was to identify the prevalence of monoclonal gammopathy of undetermined significance (MGUS) in different groups of age and the clinical features in China. This multicenter prospective study enrolled 1797 health subjects. The overall prevalence of MGUS was 2.73%. The prevalence of different age groups was 1.19% (41‐50 y), 1.16% (51‐60 y), 2.19% (61‐70 y), 3.66% (71‐80 y), and 7.76% (≥81 y). The prevalence of MGUS in male (n = 843) was 2.97%, while the prevalence of MGUS in female (n = 952) was 2.52%, but this difference of the two groups was not statistically significant. As for subtype of MGUS, IgG subtype was 55.1% (27 cases), IgA subtype was 14.3%, and IgM subtype was 12.2%. The M protein of one case became negative after 3 months, and the others remained positive without obvious disease transformation (follow‐up duration: 3‐7 mo). Thus, the prevalence of MGUS in China was similar to that in Mexican Americans, but lower than that in the other Asian country, American Whites, American Blacks, and Africans, and had a trend of increase with age. Male had higher prevalence of MGUS in China. The most common subtype was IgG.
format Online
Article
Text
id pubmed-6585751
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-65857512019-06-27 Monoclonal gammopathy of undetermined significance in Chinese population: A prospective epidemiological study Ma, Ling Xu, Shuang Qu, Jianhua Hou, Jian Wang, Yang Wen, Lei Liu, Yang Kang, Ying Jiang, Ming Fu, Weijun Du, Juan Zhou, Lin Huang, Xiaojun Zhang, Zhaoxia Lu, Jin Hematol Oncol Original Research Articles The aim of this study was to identify the prevalence of monoclonal gammopathy of undetermined significance (MGUS) in different groups of age and the clinical features in China. This multicenter prospective study enrolled 1797 health subjects. The overall prevalence of MGUS was 2.73%. The prevalence of different age groups was 1.19% (41‐50 y), 1.16% (51‐60 y), 2.19% (61‐70 y), 3.66% (71‐80 y), and 7.76% (≥81 y). The prevalence of MGUS in male (n = 843) was 2.97%, while the prevalence of MGUS in female (n = 952) was 2.52%, but this difference of the two groups was not statistically significant. As for subtype of MGUS, IgG subtype was 55.1% (27 cases), IgA subtype was 14.3%, and IgM subtype was 12.2%. The M protein of one case became negative after 3 months, and the others remained positive without obvious disease transformation (follow‐up duration: 3‐7 mo). Thus, the prevalence of MGUS in China was similar to that in Mexican Americans, but lower than that in the other Asian country, American Whites, American Blacks, and Africans, and had a trend of increase with age. Male had higher prevalence of MGUS in China. The most common subtype was IgG. John Wiley and Sons Inc. 2018-10-01 2019-02 /pmc/articles/PMC6585751/ /pubmed/30117173 http://dx.doi.org/10.1002/hon.2548 Text en © 2018 The Authors Hematological Oncology Published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research Articles
Ma, Ling
Xu, Shuang
Qu, Jianhua
Hou, Jian
Wang, Yang
Wen, Lei
Liu, Yang
Kang, Ying
Jiang, Ming
Fu, Weijun
Du, Juan
Zhou, Lin
Huang, Xiaojun
Zhang, Zhaoxia
Lu, Jin
Monoclonal gammopathy of undetermined significance in Chinese population: A prospective epidemiological study
title Monoclonal gammopathy of undetermined significance in Chinese population: A prospective epidemiological study
title_full Monoclonal gammopathy of undetermined significance in Chinese population: A prospective epidemiological study
title_fullStr Monoclonal gammopathy of undetermined significance in Chinese population: A prospective epidemiological study
title_full_unstemmed Monoclonal gammopathy of undetermined significance in Chinese population: A prospective epidemiological study
title_short Monoclonal gammopathy of undetermined significance in Chinese population: A prospective epidemiological study
title_sort monoclonal gammopathy of undetermined significance in chinese population: a prospective epidemiological study
topic Original Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585751/
https://www.ncbi.nlm.nih.gov/pubmed/30117173
http://dx.doi.org/10.1002/hon.2548
work_keys_str_mv AT maling monoclonalgammopathyofundeterminedsignificanceinchinesepopulationaprospectiveepidemiologicalstudy
AT xushuang monoclonalgammopathyofundeterminedsignificanceinchinesepopulationaprospectiveepidemiologicalstudy
AT qujianhua monoclonalgammopathyofundeterminedsignificanceinchinesepopulationaprospectiveepidemiologicalstudy
AT houjian monoclonalgammopathyofundeterminedsignificanceinchinesepopulationaprospectiveepidemiologicalstudy
AT wangyang monoclonalgammopathyofundeterminedsignificanceinchinesepopulationaprospectiveepidemiologicalstudy
AT wenlei monoclonalgammopathyofundeterminedsignificanceinchinesepopulationaprospectiveepidemiologicalstudy
AT liuyang monoclonalgammopathyofundeterminedsignificanceinchinesepopulationaprospectiveepidemiologicalstudy
AT kangying monoclonalgammopathyofundeterminedsignificanceinchinesepopulationaprospectiveepidemiologicalstudy
AT jiangming monoclonalgammopathyofundeterminedsignificanceinchinesepopulationaprospectiveepidemiologicalstudy
AT fuweijun monoclonalgammopathyofundeterminedsignificanceinchinesepopulationaprospectiveepidemiologicalstudy
AT dujuan monoclonalgammopathyofundeterminedsignificanceinchinesepopulationaprospectiveepidemiologicalstudy
AT zhoulin monoclonalgammopathyofundeterminedsignificanceinchinesepopulationaprospectiveepidemiologicalstudy
AT huangxiaojun monoclonalgammopathyofundeterminedsignificanceinchinesepopulationaprospectiveepidemiologicalstudy
AT zhangzhaoxia monoclonalgammopathyofundeterminedsignificanceinchinesepopulationaprospectiveepidemiologicalstudy
AT lujin monoclonalgammopathyofundeterminedsignificanceinchinesepopulationaprospectiveepidemiologicalstudy
AT monoclonalgammopathyofundeterminedsignificanceinchinesepopulationaprospectiveepidemiologicalstudy